UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022668
Receipt number R000026127
Scientific Title Is the morphine necessary in periarticular cocktail injection for THA patients?
Date of disclosure of the study information 2016/06/08
Last modified on 2023/06/01 10:10:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Is the morphine necessary in periarticular cocktail injection for THA patients?

Acronym

Is the morphine necessary in periarticular cocktail injection for THA patients?

Scientific Title

Is the morphine necessary in periarticular cocktail injection for THA patients?

Scientific Title:Acronym

Is the morphine necessary in periarticular cocktail injection for THA patients?

Region

Japan


Condition

Condition

Total Hip Arthroplasty

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Is the morphine necessary in periarticular cocktail injection?

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

NRS score
rest Pain VAS
Thigh girth
Range of motion

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

with morphine
f/u until 3 mo

Interventions/Control_2

without morphine
f/u until 3 mo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

osteoarthritis
osteonecrosis
femoral neck fx.

Key exclusion criteria

lost follow up

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kentaro Iwakiri

Organization

Shiraniwa Hospital

Division name

Joint Arthroplasty Center

Zip code


Address

6-10-1 Shiraniwadai Ikoma, Nara

TEL

0743-70-0022

Email

kenpiecekenpiece@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kentaro Iwakiri

Organization

Shiraniwa Hospital

Division name

Joint Arthroplasty Center

Zip code


Address

6-10-1 Shiraniwadai Ikoma, Nara

TEL

0743-70-0022

Homepage URL


Email

kenpiecekenpiece@yahoo.co.jp


Sponsor or person

Institute

Shiraniwa Hospital Joint Arthroplasty Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 01 Month 02 Day

Date of IRB

2015 Year 02 Month 01 Day

Anticipated trial start date

2015 Year 03 Month 01 Day

Last follow-up date

2017 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 08 Day

Last modified on

2023 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026127


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name